Cardiovascular disease (CVD) remains the leading cause of death around the world. According to the European Cardiovascular Disease Statistics 2017, CVD caused 3.9 million deaths in Europe each year, which are more than half of all deaths across the European Region. This Special Issue aims to provide a comprehensive overview of state-of-the-art of Cardiovascular Medicine in Europe. We invite research papers that will consolidate our understanding in this area.
In this Special Issue, we will focus and will be interested in , but are not limited to, receiving manuscript contributions in one or more of the following areas:
• Management of Heart Failure
• Diseases of the aorta
• Myocardial disease
• Cardiovascular imaging (cardiac CT; cardiac MRI)
• Interventional cardiology
• Peripheral vascular interventions
• Heart transplantation
• Valvular heart disease
• Cardiovascular Prevention
• Arterial Hypertension
• Arrhythmias (Sudden cardiac death)
It is my pleasure to invite you to submit manuscripts on the subject “State-of-the-Art Cardiovascular Medicine in Europe 2022” for this Special Issue. Full papers and communications, as well as comprehensive reviews, are welcome. Please feel free to contact me, the guest editor, in case of further questions.
Prof. Massimo Volpe, Prof. Filippos Triposkiadis, Prof. Grigorios Korosoglou and Prof. Matteo Cameli
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.
- Updates on Post-Resuscitation Care. After the Return of Spontaneous Circulation beyond the 2021 GuidelinesAlessandro Fasolino, Sara Compagnoni, Enrico Baldi, Guido Tavazzi, ... Simone SavastanoRev. Cardiovasc. Med. 2022, 23(11), 373; https://doi.org/10.31083/j.rcm2311373119Downloads1Citations338Views
- Recurrent Spontaneous Coronary Artery Dissection: Association with Takotsubo Syndrome and Fibromuscular Dysplasia; Comprehensive ReviewShams Y-Hassan, Goran Abdula, Felix BöhmRev. Cardiovasc. Med. 2022, 23(11), 367; https://doi.org/10.31083/j.rcm231136757Downloads1Citations190Views
- Sacubitril/valsartan in Heart Failure and Beyond—From Molecular Mechanisms to Clinical RelevanceMaja Nikolic, Ivan Srejovic, Jovana Joksimovic Jovic, Jasmina Sretenovic, ... Vladimir JakovljevicRev. Cardiovasc. Med. 2022, 23(7), 238; https://doi.org/10.31083/j.rcm2307238301Downloads2Citations687Views
- Role of Echocardiography in the Management of Patients with Advanced (Stage D) Heart Failure Related to Nonischemic CardiomyopathyMichael DandelRev. Cardiovasc. Med. 2022, 23(6), 214; https://doi.org/10.31083/j.rcm230621484Downloads196Views
- Drug-coated Balloons in the Neurovascular Setting: A Comprehensive, Systematic Review of Current Use and IndicationsPhilipp von Gottberg, Alexandru Cimpoca, Christina Wendl, José E. Cohen, ... Hans HenkesRev. Cardiovasc. Med. 2022, 23(4), 128; https://doi.org/10.31083/j.rcm2304128140Downloads2Citations279Views
- Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney DiseaseRiccardo Nevola, Maria Alfano, Pia Clara Pafundi, Chiara Brin, ... Alfredo CaturanoRev. Cardiovasc. Med. 2022, 23(3), 106; https://doi.org/10.31083/j.rcm2303106654Downloads11Citations1479Views
- Treatment of myocardial ischaemia-reperfusion injury in patients with ST-segment elevation myocardial infarction: promise, disappointment, and hopeJingzhou He, Nick G Bellenger, Andrew J Ludman, Angela C Shore, W David StrainRev. Cardiovasc. Med. 2022, 23(1), 23; https://doi.org/10.31083/j.rcm2301023359Downloads7Citations863Views
- Disparities between guideline statements on acute and post-acute management of cervical artery dissectionLukas Mayer-Suess, Tamara Peball, Silvia Komarek, Benjamin Dejakum, ... Michael KnoflachRev. Cardiovasc. Med. 2022, 23(1), 9; https://doi.org/10.31083/j.rcm2301009187Downloads506Views
- Right ventricular myocardial infarction: pathophysiology, clinical implications and managementGiuseppe Femia, John K French, Craig Juergens, Dominic Leung, Sidney LoRev. Cardiovasc. Med. 2021, 22(4), 1229–1240; https://doi.org/10.31083/j.rcm22041311823Downloads4Citations3886Views
- Determinants of exercise adherence and maintenance among patients with hypertension: a narrative reviewSusana Lopes, Gonçalo Félix, José Mesquita-Bastos, Daniela Figueiredo, ... Fernando RibeiroRev. Cardiovasc. Med. 2021, 22(4), 1271–1278; https://doi.org/10.31083/j.rcm2204134524Downloads12Citations970Views
- Amiodarone in ventricular arrhythmias: still a valuable resource?Luigi Pannone, Giuseppe D’Angelo, Simone Gulletta, Giulio Falasconi, ... Pasquale VergaraRev. Cardiovasc. Med. 2021, 22(4), 1383–1392; https://doi.org/10.31083/j.rcm22041431267Downloads4Citations2965Views
- Cardiovascular outcomes of glucose lowering therapy in chronic kidney disease patients: a systematic review with meta-analysisAnna Kamdar, Robert Sykes, Andrew Morrow, Kenneth Mangion, Colin BerryRev. Cardiovasc. Med. 2021, 22(4), 1479–1490; https://doi.org/10.31083/j.rcm2204152336Downloads1257Views